Gera L - Search Results

1

Noncompetitive nature of oxytocin antagonists with general structure Mpa(1)Xxx(2)Sar(7)Arg(8).

Havass J, Bakos K, Márki A, Gáspár R, Gera L, Stewart JM, Fülöp F, Tóth GK, Zupkó I, Falkay G. Havass J, et al. Among authors: gera l. Peptides. 2002 Aug;23(8):1419-25. doi: 10.1016/s0196-9781(02)00082-7. Peptides. 2002. PMID: 12182942

2

Structure activity relationships for bradykinin antagonists on the inhibition of cytokine release and the release of histamine.

Reissmann S, Pineda F, Vietinghoff G, Werner H, Gera L, Stewart JM, Paegelow I. Reissmann S, et al. Among authors: gera l. Peptides. 2000 Apr;21(4):527-33. doi: 10.1016/s0196-9781(00)00171-6. Peptides. 2000. PMID: 10822108

3

Pseudopeptide analogs of bradykinin and bradykinin antagonists.

Vavrek RJ, Gera L, Stewart JM. Vavrek RJ, et al. Among authors: gera l. Agents Actions Suppl. 1992;38 ( Pt 1):565-71. doi: 10.1007/978-3-0348-7321-5_69. Agents Actions Suppl. 1992. PMID: 1466297

4

Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7.

Vavrek RJ, Gera L, Stewart JM. Vavrek RJ, et al. Among authors: gera l. Agents Actions Suppl. 1992;38 ( Pt 1):572-81. doi: 10.1007/978-3-0348-7321-5_70. Agents Actions Suppl. 1992. PMID: 1466298

5

A new class of bradykinin antagonists containing indanylglycine.

Gera L, Stewart JM. Gera L, et al. Immunopharmacology. 1996 Jun;33(1-3):174-7. doi: 10.1016/0162-3109(96)00098-7. Immunopharmacology. 1996. PMID: 8856143 No abstract available.

6

Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy.

Taraseviciene-Stewart L, Scerbavicius R, Stewart JM, Gera L, Demura Y, Cool C, Kasper M, Voelkel NF. Taraseviciene-Stewart L, et al. Among authors: gera l. Peptides. 2005 Aug;26(8):1292-300. doi: 10.1016/j.peptides.2005.03.050. Peptides. 2005. PMID: 15878794

7

Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.

Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA Jr, Taraseviciene-Stewart L. Stewart JM, et al. Among authors: gera l. Peptides. 2005 Aug;26(8):1288-91. doi: 10.1016/j.peptides.2005.03.052. Peptides. 2005. PMID: 15878795

8

Synthesis and stereochemistry of 8,13-diaza-2,3-dimethoxygona-1,3,5(10),9(11)-tetraen-12-one and D-homo derivatives.

Göndös G, Gera L, Tóth G, Kálmán A, Bridson J. Göndös G, et al. Among authors: gera l. Steroids. 1998 Jul-Aug;63(7-8):375-82. doi: 10.1016/s0039-128x(98)00011-7. Steroids. 1998. PMID: 9654643

9

Oral activity of peptide bradykinin antagonists following intragastric administration in the rat.

Whalley ET, Hanson WL, Stewart JM, Gera L. Whalley ET, et al. Among authors: gera l. Can J Physiol Pharmacol. 1997 Jun;75(6):629-32. Can J Physiol Pharmacol. 1997. PMID: 9276140

10

The importance of the N-terminal beta-turn in bradykinin antagonists.

Miskolzie M, Gera L, Stewart JM, Kotovych G. Miskolzie M, et al. Among authors: gera l. J Biomol Struct Dyn. 2000 Oct;18(2):249-60. doi: 10.1080/07391102.2000.10506663. J Biomol Struct Dyn. 2000. PMID: 11089646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters